Acute effect of essential oil of Eugenia caryophyllata on cognition and pain in mice

  • Sumita HalderEmail author
  • Ashish K. Mehta
  • Pramod K. Mediratta
  • Krishna K. Sharma
Original Article


The essential oil of Eugenia caryophyllata (clove oil; Family: Myrtaceae) is used in dental care as an antiseptic and analgesic. The study aims to evaluate the effect of clove oil on experimental models of pain and cognition in mice. To observe the acute effects of clove oil at different doses, the elevated plus maze was used for the assessment of cognition, and the tail flick and formalin tests were used for the study of pain. The formalin test showed that clove oil (0.1 ml/kg, i.p.) demonstrated significantly reduced pain response in both the phases. The lower doses (0.025 and 0.05 ml/kg, i.p.) reduced the formalin-induced pain response significantly in the second phase only. The tail-flick test showed variable response. The dose 0.1 ml/kg, clove oil, significantly decreased the tail-flick latency at 30 min and this effect was reversed by naloxone (1 mg/kg). On the contrary, the dose 0.025 ml/kg of clove oil, at 30 and 60 min increased the mean tail-flick latency compared to control group, but this effect was not statistically significant. Yet naloxone significantly (p < 0.05) reversed the effect of clove oil 0.025 ml/kg at 30 min. Clove oil (0.025 and 0.05 ml/kg, i.p.) significantly reversed the scopolamine-induced retention memory deficit induced by scopolamine, but clove oil (0.1 ml/kg, i.p.) significantly reversed both acquisition as well as retention deficits in elevated plus maze induced by the scopolamine. Clove oil exhibits reduced pain response by a predominantly peripheral action as evidenced by formalin test and the tail flick test showed the involvement of opioid receptors. Clove oil also significantly improved scopolamine-induced retention memory deficit at all doses.


Eugenia caryophyllata Myrtaceae Tail flick test Formalin test Elevated plus maze Transfer latency 


  1. Abbott FV, Franklin KB, Westbrook RF (1995) The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60:91–102PubMedCrossRefGoogle Scholar
  2. Arora T, Mehta AK, Sharma KK, Mediratta PK, Banerjee BD, Garg GR, Sharma AK (2010) Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic Clin Pharmacol Toxicol 106:372–377PubMedCrossRefGoogle Scholar
  3. Bell RF (1999) Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 83:101–103PubMedCrossRefGoogle Scholar
  4. Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, Bakhrouf A (2007) The chemical composition and biological activity of clove essential oil, E. caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res 21:501–506PubMedCrossRefGoogle Scholar
  5. Cotter PA, Rodnick KJ (2006) Differential effects of anesthetics on electrical properties of the rainbow trout (Oncorhynchus mykiss) heart. Comp Biochem Physiol 145:158–165CrossRefGoogle Scholar
  6. D’Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79Google Scholar
  7. Date KB, Kulkarni PH (1995) Assessment of Rasadanti in various oral disorders. Ayurveda Res Pap II:165–175Google Scholar
  8. Fasmer OB, Berge OG, Hole K (1985) Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Different effects in the formalin and tail–flick tests. Neuropharmacology 24:729–734PubMedCrossRefGoogle Scholar
  9. Guénette SA, Ross A, Marier JF, Beaudry F, Vachon P (2007) Pharmacokinetics of eugenol and its effects on thermal hypersensitivity in rats. Eur J Pharmacol 562:60–67PubMedCrossRefGoogle Scholar
  10. Halder S, Bharal N, Mediratta PK, Kaur I, Sharma KK (2009) Anti-inflammatory, immunomodulatory and antinociceptive activity of Terminalia arjuna Roxb bark powder in mice and rats. Indian J Exp Biol 47:577–583PubMedGoogle Scholar
  11. Halder S, Mehta AK, Kar R, Mustafa M, Mediratta PK, Sharma KK (2011) Clove oil reverses learning and memory deficits in scopolamine-treated mice. Planta Med 77:830–834PubMedCrossRefGoogle Scholar
  12. Hirafuji M (1984) Inhibition of prostaglandin I2 biosynthesis in rat dental pulp by phenolic dental medicaments. Jpn J Pharmacol 36:544–546PubMedCrossRefGoogle Scholar
  13. Holtman JR Jr, Wala EP (2005) Characterization of morphine-induced hyperalgesia in male and female rats. Pain 114:62–70PubMedCrossRefGoogle Scholar
  14. Islam AK, Cooper ML, Bodnar RJ (1993) Interactions among aging, gender, and gonadectomy effects upon morphine antinociception in rats. Physiol Behav 54:45–53PubMedCrossRefGoogle Scholar
  15. Itoh J, Nabeshima T, Kameyama T (1991) Utility of elevated plus-maze for dissociation of amnesic and behavioural effects of drugs in mice. Eur J Pharmacol 194:71–76PubMedCrossRefGoogle Scholar
  16. Jirovetz L, Buchbauer G, Stoilova I, Stoyanova A, Krastanov A, Schmidt E (2006) Chemical composition and antioxidant properties of clove leaf essential oil. J Agric Food Chem 54:6303–6307PubMedCrossRefGoogle Scholar
  17. Jourdan D, Pickering G, Marchand F, Gaulier JM, Alliot J, Eschalier A (2002) Impact of ageing on the antinociceptive effect of reference analgesics in the Lou/c rat. Br J Pharmacol 137:813–820PubMedCrossRefGoogle Scholar
  18. Khanna N, Malhotra RS, Mehta AK, Garg GR, Halder S, Sharma KK (2011) Interaction of morphine and potassium channel openers on experimental models of pain in mice. Fundam Clin Pharmacol 25(4):479–484. doi: 10.1111/j.1472-8206.2010.00880.x PubMedCrossRefGoogle Scholar
  19. Kim B, Kim J, Kim H, Heo M (1997) Biological screening of 100 plants for cosmetic use: II. Antioxidative activity and free radical scavenging activity. Int J Cosmet Sci 19:299–307PubMedCrossRefGoogle Scholar
  20. Kozam G (1977) The effect of eugenol on nerve transmission. Oral Surg 44:799–805PubMedCrossRefGoogle Scholar
  21. Kumar V, Singh PN, Muruganandam AV, Bhattacharya SK (2000) Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J Ethnopharmacol 72:119–128PubMedCrossRefGoogle Scholar
  22. Kurian R, Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL (2006) Effects of eugenol on animal models of nociception. Indian J Pharmacol 38:341–345CrossRefGoogle Scholar
  23. Markowitz K, Moynihan M, Liu M, Kim S (1992) Biological properties of eugenol and zinc oxide-eugenol. A clinically oriented review. Oral Surg Oral Med Oral Pathol 73:729–737PubMedCrossRefGoogle Scholar
  24. Mogil JS, Wilson SG (1997) Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies. Eur J Pain 1:293–297PubMedCrossRefGoogle Scholar
  25. Ogata M, Hoshi M, Urano S, Endo T (2000) Antioxidant activity of eugenol and related monomeric and dimeric compounds. Chem Pharm Bull 48:1467–1469PubMedCrossRefGoogle Scholar
  26. Okhubo T, Kitamura K (1997) Eugenol activates Ca2+-permeable currents in rat dorsal root ganglion cells. J Dent Res 76:1737–1744CrossRefGoogle Scholar
  27. Ozeki M (1975) The effects of eugenol on nerve and muscle and crayfish. Comp Biochem Physiol 50:183–191Google Scholar
  28. Park SP, Kwon SH (2008) Cognitive effects of antiepileptic drugs. J Clin Neurol 4:99–106PubMedCrossRefGoogle Scholar
  29. Park SH, Sim YB, Lee JK, Kim SM, Kang YJ, Jung JS, Suh HW (2011) The analgesic effects and mechanisms of orally administered eugenol. Arch Pharm Res 34:501–507PubMedCrossRefGoogle Scholar
  30. Pawar VC, Thakur VS (2006) In vitro efficacy of 75 essential oils against Aspergillus niger. Mycoses 49:316–323PubMedCrossRefGoogle Scholar
  31. Porro CA, Facchinetti F, Pozzo P, Benassi C, Biral GP, Genazzani AR (1988) Tonic pain time-dependently affects beta-endorphin-like immunoreactivity in the ventral periaqueductal gray matter of the rat brain. Neurosci Lett 86:89–93PubMedCrossRefGoogle Scholar
  32. Pourgholami MH, Kamalinejad M, Javadi M, Majzoob S, Sayyah M (1999) Evaluation of the anticonvulsant activity of the essential oil of E. caryophyllata in male mice. J Ethnopharmacol 64:167–171PubMedCrossRefGoogle Scholar
  33. Prashar A, Locke IC, Evans CS (2006) Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells. Cell Prolif 39:241–248PubMedCrossRefGoogle Scholar
  34. Sensch O, Vierling W, Brandt W, Reiter W (2000) Effects of inhibition of calcium and potassium currents in guinea-pig cardiac contraction: comparison of beta-caryophyllene oxide, eugenol, and nifedipine. Br J Pharmacol 131:1089–1096PubMedCrossRefGoogle Scholar
  35. Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic pain response. Pain 38:347–352PubMedCrossRefGoogle Scholar
  36. Smith MA, Gray JD (2001) Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor. Psychopharmacology 156:445–453PubMedCrossRefGoogle Scholar
  37. Sneddon IB, Glew RC (1973) Contact dermatitis due to propanidid in an anaesthetist. Practitioner 211:321–323PubMedGoogle Scholar
  38. Son KH, Kwon SY, Kim HP, Chang HW, Kang SS (1998) Constituents of Syzigium aromaticum Merr. et Perry. Nat Prod Sci 4:263–267Google Scholar
  39. Stoffel EC, Ulibarri CM, Craft RM (2003) Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103:285–302PubMedCrossRefGoogle Scholar
  40. Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ (2003) Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 106:381–391PubMedCrossRefGoogle Scholar
  41. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51:5–17PubMedCrossRefGoogle Scholar
  42. Trowbridge H, Edwall L, Panopaulos P (1982) Effect of zinc oxide, eugenol and calcium hydroxide on intradental nerve activity. J Endod 8:403–406PubMedCrossRefGoogle Scholar
  43. Ukai M, Miura M, Kameyama T (1995) Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides 16:1283–1286PubMedCrossRefGoogle Scholar
  44. Venkateshweri Y, Babu RJ, Sampathkumar D, Mittal N, Pandit JK (1995) Development of low cost tetracycline strip for long term treatment of periodontal disease. Indian Drugs 32:205–210Google Scholar
  45. Wie MB, Won MH, Lee KH, Shin JH, Lee JC, Suh HW, Song DK, Kim YH (1997) Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci Lett 225:93–96PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Sumita Halder
    • 1
    Email author
  • Ashish K. Mehta
    • 2
  • Pramod K. Mediratta
    • 1
  • Krishna K. Sharma
    • 1
  1. 1.Department of PharmacologyUniversity College of Medical Sciences, University of DelhiDelhiIndia
  2. 2.Department of PhysiologyUniversity College of Medical Sciences, University of DelhiDelhiIndia

Personalised recommendations